- Home
- KF vs MLSS Comparison
KF vs MLSS Comparison
Compare KF & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KF
- MLSS
- Stock Information
- Founded
- KF 1984
- MLSS 1989
- Country
- KF United States
- MLSS United States
- Employees
- KF N/A
- MLSS N/A
- Industry
- KF Investment Managers
- MLSS Industrial Specialties
- Sector
- KF Finance
- MLSS Health Care
- Exchange
- KF Nasdaq
- MLSS Nasdaq
- Market Cap
- KF 90.9M
- MLSS 74.5M
- IPO Year
- KF N/A
- MLSS 1995
- Fundamental
- Price
- KF $22.93
- MLSS $0.94
- Analyst Decision
- KF
- MLSS Buy
- Analyst Count
- KF 0
- MLSS 1
- Target Price
- KF N/A
- MLSS $1.25
- AVG Volume (30 Days)
- KF 18.4K
- MLSS 60.4K
- Earning Date
- KF 01-01-0001
- MLSS 05-15-2025
- Dividend Yield
- KF N/A
- MLSS N/A
- EPS Growth
- KF N/A
- MLSS N/A
- EPS
- KF N/A
- MLSS N/A
- Revenue
- KF N/A
- MLSS $8,613,503.00
- Revenue This Year
- KF N/A
- MLSS $29.14
- Revenue Next Year
- KF N/A
- MLSS $20.19
- P/E Ratio
- KF N/A
- MLSS N/A
- Revenue Growth
- KF N/A
- MLSS N/A
- 52 Week Low
- KF $18.30
- MLSS $0.58
- 52 Week High
- KF $25.56
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- KF 67.99
- MLSS 45.44
- Support Level
- KF $21.20
- MLSS $0.90
- Resistance Level
- KF $22.87
- MLSS $1.02
- Average True Range (ATR)
- KF 0.36
- MLSS 0.07
- MACD
- KF 0.10
- MLSS -0.00
- Stochastic Oscillator
- KF 98.86
- MLSS 29.19
About KF Korea Fund Inc. (The) New
Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and others.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.